Osteoclast formation was enhanced approximately 5-fold (P &lt; 0.001) and bone resorption approximately 10-fold (P &lt; 0.001) in CED patients, and the increase in osteoclast formation was inhibited by soluble TGFbeta type II receptor.
C0011989
Camurati-Engelmann Syndrome